Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

DMCM, a benzodiazepine site inverse agonist, improves active avoidance and motivation in the rat. (CROSBI ID 186490)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Samardžić, Janko ; Švob Štrac, Dubravka ; Obradović, Miljana ; Oprić, Dejan ; Obradović, Dragan I. DMCM, a benzodiazepine site inverse agonist, improves active avoidance and motivation in the rat. // Behavioural brain research, 235 (2012), 2; 195-199. doi: 10.1016/j.bbr.2012.07.032

Podaci o odgovornosti

Samardžić, Janko ; Švob Štrac, Dubravka ; Obradović, Miljana ; Oprić, Dejan ; Obradović, Dragan I.

engleski

DMCM, a benzodiazepine site inverse agonist, improves active avoidance and motivation in the rat.

There are several modulatory sites at GABA(A) receptors, which mediate the actions of many drugs, among them benzodiazepine. Three kinds of allosteric modulators act through the benzodiazepine binding site: positive (agonist), neutral (antagonist), and negative (inverse agonist). The goal of the present study was to examine the influence of the inverse agonist methyl 6, 7-dimethoxy-4-ethyl-beta-carboline-3- carboxylate (DMCM) acting on α GABA(A) receptor and compare its dose-response effects on memory and depression-like behavior. We independently studied the effects of DMCM (0.05-1.0mg/kg) on retention versus acquisition of active avoidance and depression-like behavior in the forced swim test. Throughout the study, drugs were given intraperitoneally, 30 min before testing. ANOVA has showed that treatment with DMCM significantly affected retrieval of avoidance response (p<0.05), exerted promnesic effects in inverted U-shape manner. Dunnett's test indicated that the DMCM avoidance-facilitatory dose was 0.1 mg/kg. At the dose facilitating retrieval of avoidance memory, DMCM significantly (p<0.05, comparison of regression coefficients by Student's t-test) and progressively increased acquisition rate during 5 days training, compared to the saline group. In forced swim test, ANOVA indicated statistically significant effects of DMCM (p<0.05). Dunnett's analysis showed that DMCM significantly decreased immobility time at the dose of 0.1 mg/kg, exerted acute antidepressant-like effects. Our results experimentally support the findings that under certain circumstances, nonselective benzodiazepine site inverse agonists, produce memory-enhancing and antidepressant-like effects. The molecular and neuronal substrates linking the actions of specific GABA-benzodiazepine receptor complex subunits remains to be further elucidated.

GABA-A receptor; Inverse agonist; Depression; Memory; Forced swim test; Active avoidance

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

235 (2)

2012.

195-199

objavljeno

0166-4328

10.1016/j.bbr.2012.07.032

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost